###begin article-title 0
###xml 11 14 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
Motifs and cis-regulatory modules mediating the expression of genes co-expressed in presynaptic neurons
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
An integrative strategy of comparative genomics, experimental and computational approaches reveals aspects of a regulatory network controlling neuronal-specific expression in presynaptic neurons.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
Hundreds of proteins modulate neurotransmitter release and synaptic plasticity during neuronal development and in response to synaptic activity. The expression of genes in the pre- and post-synaptic neurons is under stringent spatio-temporal control, but the mechanism underlying the neuronal expression of these genes remains largely unknown.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 377 380 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
Using unbiased in vivo and in vitro screens, we characterized the cis elements regulating the Rab3A gene, which is expressed abundantly in presynaptic neurons. A set of identified regulatory elements of the Rab3A gene corresponded to the defined Rab3A multi-species conserved elements. In order to identify clusters of enriched transcription factor binding sites, for example, cis-regulatory modules, we analyzed intergenic multi-species conserved elements in the vicinity of nine presynaptic genes, including Rab3A, that are highly and specifically expressed in brain regions. Sixteen transcription factor binding motifs were over-represented in these multi-species conserved elements. Based on a combined occurrence for these enriched motifs, multi-species conserved elements in the vicinity of 107 previously identified presynaptic genes were scored and ranked. We then experimentally validated the scoring strategy by showing that 12 of 16 (75%) high-scoring multi-species conserved elements functioned as neuronal enhancers in a cell-based assay.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
This work introduces an integrative strategy of comparative genomics, experimental, and computational approaches to reveal aspects of a regulatory network controlling neuronal-specific expression of genes in presynaptic neurons.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 615 616 615 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1267 1268 1267 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1269 1270 1269 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
Synaptic transmission, the crucial process that enables information transfer in the nervous system, is a series of events in which neurotransmitters are released via exocytosis from presynaptic neurons and taken up by postsynaptic neurons. In presynaptic neurons, synaptic vesicles facilitate uptake of neurotransmitters and dock at the active zone of the plasma membrane. In response to calcium signaling, vesicles rapidly fuse with the plasma membrane and release neurotransmitters by exocytosis. The vesicles are recycled by subsequent endocytosis. These events are orchestrated by multiple protein complexes [1,2]. For example, one class of proteins is attached to the synaptic vesicle membrane, and is involved in calcium sensing (SYT1 and SV2a), membrane fusion (VAMP1), and vesicle recycling (SCAMP5). Another group of proteins is bound with scaffold proteins or directly anchored at the active zone and functions in vesicle docking (SYN1 and RIMs), priming (RIMs) and fusion (SNAP25 and STXBP1). In addition to these proteins, RAB3 proteins (RAB3A and RAB3C) function as molecular linkers between synaptic vesicles and the active zone by cycling between vesicle-associated and dissociated forms and interacting with multiple effectors, such as RIMs and SYN1 [3-5].
###end p 10
###begin p 11
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Syp </italic>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sv2a </italic>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 704 710 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1104 1106 1104 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1291 1294 1291 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 428 433 <span type="species:ncbi:10090">mouse</span>
To ensure precisely controlled synaptic communication, members of protein complexes in presynaptic neurons have highly coordinated expression and protein localization [6-9]. Spatial and temporal expression patterns of several presynaptic genes have been reported in detail. For instance, in mammalian brain, Rab3A is expressed throughout all brain regions, including cortex, hippocampus, cerebellum and thalamus [10,11]. In the mouse, detectable levels of Rab3A, Syp and Sv2a mRNAs are reported from embryonic day 9.5 or 10.5, an early neurogenesis stage in which progenitors gradually undergo cell cycle withdrawal and neuronal differentiation [12-14]. During neuronal maturation and synapse formation, Rab3A expression dramatically increases and the protein becomes localized to the presynaptic terminal of neurons [15,16]. In contrast to the increased expression during neuronal development, neurodegenerative and psychiatric disorders such as Alzheimer's, Huntington's disease and schizophrenia are marked by decreased levels of RAB3A, SYT1, and SNAP25, coupled with the loss of functional synapses [17-19]. It is clear that both gene expression and protein distribution in presynaptic neurons are tightly regulated during neuronal development, differentiation and maintenance. However, cis-regulatory mechanisms mediating the neuronal expression of presynaptic genes still remain unknown.
###end p 11
###begin p 12
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 261 269 261 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 555 558 555 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
Comparative genomics has taken advantage of the increasing number of whole genome sequences available for many model organisms in order to identify unknown regulatory elements [20-26]. For example, 353 of 868 multi-species conserved elements (MCEs) examined by in vivo enhancer assay using mouse transgenesis were associated with tissue-specific expression of the reporter gene [27,28]. Furthermore, investigations of the promoter regions of co-expressed genes have led to discovery of significant clusters of transcription factor binding sites, that is, cis-regulatory modules (CRMs) [29-33]. Although these common CRMs are statistically over-represented in regulatory elements of co-expressed genes, their arrangement and activity may vary greatly [34-36]. Therefore, co-expressed genes defined from large-scale expression studies provide excellent means to study common tissue-specific regulatory modules.
###end p 12
###begin p 13
###xml 218 226 218 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 230 239 230 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 250 253 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
To elucidate the common CRMs regulating neuronal-specific expression of presynaptic genes, we first defined a cluster of nine presynaptic genes that were highly and specifically expressed in neuronal tissues. Unbiased in vivo and in vitro screens of cis-regulatory sites for Rab3A, one of the nine genes, revealed regulatory roles for all MCEs in the vicinity of this gene. We thus identified motifs of 16 transcription factors that were enriched in intergenic MCEs of the nine presynaptic genes in comparison to ubiquitously expressed genes. Identified CRMs were then used to develop a novel metric to rank MCEs according to their potential for mediating neuronal-specific expression. By experimentally validating the high-scoring as well as the low-scoring MCEs, we confirmed that this CRM-based scoring metric accurately identified neuronal-specific regulatory elements.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Gene selection for neuronal-restricted expression
###end title 15
###begin p 16
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 707 712 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3C</italic>
###xml 714 720 714 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scamp5</italic>
###xml 722 728 722 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snap25</italic>
###xml 730 736 730 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stxbp1</italic>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Syn1</italic>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sv2a</italic>
###xml 750 758 750 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Camk2N1 </italic>
###xml 762 766 762 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnm1</italic>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 881 882 881 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 1074 1076 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
In our previous work, we performed comparative sequence analysis of presynaptic genes encoding proteins mainly present in the presynaptic nerve terminal [37]. To select genes with neuronal-restricted expression, we used SymAtlas to examine the expression profiles of these genes obtained by microarray analysis in 54 mouse non-redundant tissues and at 7 developmental stages [38]. Expression profiles for 107 presynaptic genes, represented by 161 oligonucleotide gene probes with a consistent expression pattern, were available. A hierarchical k-means clustering of the 107 gene expression patterns revealed three distinct groups (Figure 1; Table S1 in Additional data file 1): nine genes, including Rab3A, Rab3C, Scamp5, Snap25, Stxbp1, Syn1, Sv2a, Camk2N1 and Dnm1, are tightly clustered with the most abundant expression restricted to brain tissues (cluster 1, Figure 1a, Table 1); 27 genes are grouped with moderate neuronal expression (cluster 2, Figure 1b); and 71 genes are expressed in all tested tissues with an ubiquitous or nonspecific pattern (cluster 3, Figure 1c).
###end p 16
###begin p 17
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression analysis of 107 presynaptic genes across mouse tissues and developmental stages</bold>
###xml 269 273 269 273 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 381 385 381 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 497 501 497 501 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Expression analysis of 107 presynaptic genes across mouse tissues and developmental stages. Expression profile of 107 genes corresponding to 161 oligonucleotide gene probes were clustered into 3 distinct expression groups by the hierarchical k-means clustering method. (a) Cluster 1: transcripts with high expression in brain tissues and low levels of expression in other tissues. (b) Cluster 2: transcripts with moderate expression in brain tissues and low levels of expression in other tissues. (c) Cluster 3: transcripts with widespread but low levels of expression in most tested tissues.
###end p 17
###begin p 18
Clustering of nine presynaptic genes highly expressed in brain
###end p 18
###begin p 19
List of the nine genes in cluster 1 with strong neuronal expression. A more complete list of genes in the three clusters is available in Table S1 in Additional data file 1.
###end p 19
###begin p 20
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 370 376 370 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 476 482 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 629 635 629 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 927 933 927 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 520 525 <span type="species:ncbi:10090">mouse</span>
###xml 527 530 <span type="species:ncbi:10116">rat</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
Given that genes in cluster 1 were highly similar in their expression pattern, we asked whether they share potential cis-regulatory elements critical for neuronal-specific expression. Our strategy involved a systematic mapping of cis-regulatory elements for one gene (Rab3A), and then using these data as a guide to characterize the regulatory elements for other genes. Rab3A is well-suited for this case study for several reasons. First, the exclusive neuronal expression of Rab3A is conserved among mammalian species (mouse, rat and human), suggesting that common regulatory mechanisms may be evolutionarily conserved. Second, Rab3A is a small gene spanning a 3 kb genomic region with a 4.3 kb upstream intergenic region. This short genomic interval allows a systematic analysis of the entire region for functional regulatory elements. We followed a two-pronged approach to precisely characterize regulatory elements for the Rab3A gene: an assessment of multiple-species conserved elements (MCEs) and an unbiased screen for functional elements with a series of deletions.
###end p 20
###begin title 21
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
Identification of a genomic region sufficient for Rab3A neuronal-specific expression
###end title 21
###begin p 22
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pd4c </italic>
###xml 99 108 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BC051227 </italic>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 574 580 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2d</xref>
###xml 1023 1024 1023 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 588 593 <span type="species:ncbi:10090">mouse</span>
###xml 666 671 <span type="species:ncbi:10090">mouse</span>
The Rab3A gene resides in one of the most gene-rich regions on mouse chromosome 8 between Pd4c and BC051227 (Figure 2a). Two Rab3A transcripts were found in the GeneBank mRNA database: a longer transcript containing a 374 bp 5' untranslated region (UTR) adjacent to the first exon, defined as the RefSeq transcript (build 37 assembly by NCBI); a shorter transcript containing a 156 bp 5' UTR 1,000 bp upstream of the first exon, reported in genome-wide transcriptome analysis [39] (Figure 2b). To validate these two transcripts, we examined the presence of the two distinct Rab3A mRNA in mouse brain by RT-PCR and quantitative PCR. Both transcripts were detected in mouse cortex at 12.5 days post coitum (dpc), 14.5 dpc, 17.5 dpc, postnatal day 1, postnatal day 7 and 6 months stages (Figure 2c). Quantitative analysis showed that the short transcript was the predominant form (Figure 2d). Although the RefSeq transcript corresponds to the long transcript, this mRNA was expressed at low level in all tested stages (Figure 2; Figure S1 in Additional data file 2).
###end p 22
###begin p 23
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Characterization of <italic>Rab3A </italic>transcripts</bold>
###xml 39 43 39 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 155 161 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 271 275 271 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 601 605 601 605 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 617 623 617 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 809 815 809 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 822 833 822 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 925 929 922 926 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 962 968 959 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 1154 1160 1151 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 63 69 <span type="species:ncbi:10090">murine</span>
###xml 657 662 <span type="species:ncbi:10090">mouse</span>
Characterization of Rab3A transcripts. (a) Illustration of the murine Rab3A locus in the University of California at Santa Cruz (UCSC) Genome Browser. Two Rab3A transcripts are shown in the top panel, among which the RefSeq transcript is represented as dark blue blocks. (b) Two splicing forms of Rab3A are labeled as LT (longer transcript) and ST (shorter transcript). The 5' UTR of Rab3A in the ST is shown as an unfilled box. The positions of primers used for RT-PCR are represented as solid arrows. Quantitative PCR primers are represented as open arrows and corresponding labels are in brackets. (c) Presence of Rab3A ST and LT examined by RT-PCR from mouse cortex tissues at various developmental stages. Primer set F1/R1 detects ST, primer set F2/R1 detects LT, and primer set F3/R1 reflects the total Rab3A level. beta-actin level is used as control for RNA loading. Corresponding maker size is labeled on the right. (d) Percentage of ST and LT in total Rab3A mRNA was measured by quantitative RT-PCR from the same tissues used in (b). Specific primer sets were designed for ST and LT, respectively. A control primer set was used to detect total Rab3A level. All samples were tested simultaneously with the control set and the test set (either ST or LT). The ratio between ST and total RNA is presented as blue bars, and the ratio between LT and total RNA is presented as red bars. The error bars represent the standard deviation of the mean of four replicates used for each stage.
###end p 23
###begin p 24
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 200 206 <span type="species:ncbi:10090">murine</span>
Based on this refined gene annotation, we initiated characterization of Rab3A regulatory elements by examining conserved elements in non-coding regions of the Rab3A locus. We compared the sequence of murine Rab3A to sequences of 17 vertebrate species using the UCSC genome browser [40]. The conservation profile revealed only five distinct MCEs in non-coding regions: MCE1 (-1,394, -1,216), MCE2 (-305, -137), MCE3 (-69, -2), MCE4 (+281, +500) and MCE5 (+3,381, +3,881), ranging from 76 to 82% nucleotide sequence identity between mammalian species (Figure 3a).
###end p 24
###begin p 25
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In vivo </italic>screen of genomic regions sufficient for <italic>Rab3A </italic>endogenous expression</bold>
###xml 78 82 78 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 309 315 309 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 601 607 601 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 613 617 613 617 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 852 858 852 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 879 883 879 883 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 1049 1056 1049 1056 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d, e) </bold>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
###xml 684 699 <span type="species:ncbi:10090">transgenic mice</span>
###xml 910 915 <span type="species:ncbi:10090">mouse</span>
In vivo screen of genomic regions sufficient for Rab3A endogenous expression. (a) Physical map of Rab3A locus on mouse chromosome 8, adapted from the UCSC Genome Browser. The top panel describes the 15 kb genomic region of the Rab3A locus. The middle track shows a measure of evolutionary conservation of the Rab3A locus in 17 vertebrates. Pairwise alignments of each species to the mouse genome are displayed as a grayscale density plot in which darker scale indicates higher conservation. The arrows on the bottom indicate the positions of multiple-species conserved elements (MCE1 to 5) around the Rab3A gene. (b) Schematic drawing of the EGFP reporter constructs used to generate transgenic mice. The two constructs (15 kb and 5.5 kb) were derived from the modified BAC clone RP23-433N2 containing an EGFP reporter (green block) in the position of Rab3A exon 1 (blue block). (c) Sagittal view of wild-type mouse embryos at 14.5 dpc stained with Rab3A antibody. A strong signal in the central nervous system (brain and spinal cord) was observed. (d, e) Sagittal view of transgenic embryos at 14.5 dpc stained with EGFP antibody. A strong signal in the central nervous system was observed in transgenic positive individuals, either carrying the 15 kb or 5.5 kb construct. TG-, transgenic negative; TG+, transgenic positive.
###end p 25
###begin p 26
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 353 359 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 955 961 955 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 987 991 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c-e</xref>
###xml 1236 1242 1236 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 1292 1295 1292 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1355 1360 1355 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
To examine if the 5.5 kb chromosome interval encompassing five MCEs around Rab3A was sufficient to give rise to neuronal expression of Rab3A, we tested this region by transient transgenesis using a modified bacterial artificial chromosome (BAC) clone. Specifically, the enhanced green fluorescent protein (EGFP) reporter gene replaced the first exon of Rab3A in a BAC clone (RP433N2) as described by [41]. The modified BAC clone was then truncated into two reporter constructs containing either a 15 kb genomic region (7 kb upstream and 5 kb downstream regions) or a 5.5 kb genomic region with all predicted MCEs (2.4 kb upstream and 100 bp downstream) (Figure 2b). Transgenic embryos were generated with each construct and assessed for EGFP expression at 14.5 dpc by histochemistry in three transgenic lines. Embryos carrying either the 5.5 kb or 15 kb genomic construct showed EGFP expression restricted to neural tissues, similar to that of endogenous Rab3A at the same stage (Figure 2c-e). The stronger signal in embryos carrying the 15 kb construct was likely due to high copy numbers of the EGFP reporter (data not shown). Based on the consistent neuronal expression of EGFP reporter, we concluded that the 5.5 kb region covering Rab3A coding sequence and five MCEs contained necessary cis-regulatory elements responsible for neuronal expression of Rab3A.
###end p 26
###begin title 27
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
Characterization of cis-regulatory elements in Rab3A locus by two strategies
###end title 27
###begin p 28
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 233 239 233 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 256 267 256 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 298 309 298 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 370 376 370 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 685 696 685 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 715 720 715 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b, c</xref>
###xml 758 769 758 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 868 879 868 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 971 977 971 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 565 570 <span type="species:ncbi:10090">mouse</span>
###xml 596 601 <span type="species:ncbi:9606">human</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
In vivo transgenic experiments identified a 5.5 kb genomic region containing cis-regulatory elements responsible for neuronal expression of Rab3A at 14.5 dpc. To characterize regulatory elements, it was necessary to first define the Rab3A promoter region. Luciferase vector pGL, which contains the Luciferase coding sequence without a promoter, was used to identify the Rab3A promoter region. We generated a series of deletions in the 1.5 kb upstream region of Rab3A and fused them with pGL vector. These constructs were transfected into three cell lines: Neuro2a (mouse neuroblastoma), HEK 293 (human embryonic kidney) and Hela (human adenocarcinoma) to assess their ability to drive Luciferase expression (Figure 4b, c). The MCE3 region in pGL-8 initiated Luciferase expression in all three cell lines, whereas deletion of this region in pGL-19 completely disrupted Luciferase activity even with intact upstream enhancers. Therefore, the MCE3 region was defined as the Rab3A promoter region.
###end p 28
###begin p 29
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 58 69 58 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Functional characterization of MCEs in the <italic>Rab3A </italic>locus by <italic>Luciferase </italic>assay</bold>
###xml 76 80 76 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 194 201 194 201 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b, c) </bold>
###xml 226 237 226 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 316 327 316 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 351 370 351 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Firefly Luciferase </italic>
###xml 438 449 438 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 586 597 586 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 636 655 636 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Firefly Luciferase </italic>
###xml 688 707 688 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla Luciferase </italic>
###xml 849 856 849 856 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d, e) </bold>
###xml 879 890 879 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 920 926 920 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 936 943 936 943 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f, g) </bold>
###xml 993 999 993 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 1013 1024 1013 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 1119 1126 1119 1126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(h, i) </bold>
###xml 1141 1152 1141 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 1183 1189 1183 1189 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j, k) </bold>
###xml 1291 1302 1291 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 1089 1093 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1219 1223 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1252 1256 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Functional characterization of MCEs in the Rab3A locus by Luciferase assay. (a) Gene structure of Rab3A is illustrated at the top and the transcription start site of the ST is designated as +1. (b, c) Presence of MCE3 induces Luciferase expression. The schematic representation of deletion constructs fused with pGL Luciferase reporter containing the Firefly Luciferase coding sequence (green block) but no promoter region. Corresponding Luciferase activity of each construct was measured in Neuro2a cells (blue bars), HEK293 cells (red bars) and Hela cells (yellow bars). The relative Luciferase activity was calculated by normalizing Firefly Luciferase activity to an internal control, Renilla Luciferase activity. Bars in the plot represent the mean of three independent experiments and the average standard deviation is indicated as error bars. (d, e) MCE1 and MCE2 increase Luciferase activity under the control of Rab3A promoter. (f, g) The effect of MCE1 and MCE2 is independent of the Rab3A promoter. The Luciferase construct of MCE1 or MCE2 was generated under the control of the SV40 promoter (yellow block). (h, i) MCE4 decreases Luciferase activity in three cell lines. (j, k) MCE5 under the control of the SV40 promoter (yellow block) and SV40 enhancer (orange block) decreases Luciferase activity in three cell lines.
###end p 29
###begin p 30
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 71 82 71 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 212 223 212 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 387 392 387 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4d, e</xref>
###xml 527 533 527 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 596 601 596 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4f, g</xref>
###xml 679 690 679 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4h-k</xref>
###xml 870 876 870 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 476 480 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The remaining Rab3A MCEs were then examined for their ability to drive Luciferase expression under the control of the Rab3A promoter (MCE3) in three cell lines (Table 2). Two MCEs, MCE1 and MCE2, greatly enhance Luciferase activity in the Neuro2a cell line but not in HEK293 and Hela cells, supporting their roles as independent enhancers in a neuronal cell type specific manner (Figure 4d, e). A similar induction by MCE1 and MCE2 were also observed under the control of the SV40 promoter, ruling out the possibility that the Rab3A promoter itself contributed to the neuronal expression (Figure 4f, g). In contrast, the intronic MCE4 and the MCE5 in the 3' UTR led to decreased Luciferase activity in all tested cell lines, regardless of the promoter used (Figure 4h-k). Additional experiments will be needed to accurately define the role of these negative elements on Rab3A gene regulation; they may regulate transcription as repressors, or affect transcript stability, splicing or translational efficiency.
###end p 30
###begin p 31
###xml 10 21 10 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
Change of Luciferase activity due to multi-species conserved elements in different cell lines
###end p 31
###begin p 32
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 66 77 66 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 198 209 198 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 240 246 240 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 446 457 446 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 616 627 616 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 814 825 814 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 863 874 863 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 962 973 962 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 1031 1042 1031 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 274 278 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 326 331 <span type="species:ncbi:10090">mouse</span>
###xml 357 362 <span type="species:ncbi:9606">human</span>
###xml 391 396 <span type="species:ncbi:9606">human</span>
###xml 586 590 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 687 691 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 893 897 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 911 915 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Summary of Rab3A multi-species conserved element (MCE) effects on Luciferase expression in Neuron2a, HEK293 and Hela cell lines. Rab3A MCE1, 2, 4 and 5 were examined individually by fusing into the Luciferase construct harboring either the Rab3A gene promoter (MCE3) or the SV40 promoter. Three cell lines were used: Neuro2a (mouse neuroblastoma), HEK 293 (human embryonic kidney) and Hela (human adenocarcinoma). MCE1 and MCE2 robustly enhanced Luciferase activity in the Neuro2a cell line but not at a comparable level in HEK293 and Hela cells under the control of either the MCE3 or SV40 promoter. MCE4 repressed Luciferase activity in all three cell lines, even under control of the SV40 enhancer. MCE4 also showed a strong positional effect, in which a position upstream of the MCE3 promoter failed to reduce Luciferase expression. MCE5 led to a decrease of Luciferase activity under the SV40 promoter and SV40 enhancer. However, when MCE1 and MCE2 induced Luciferase activity in Neuro2a cells, MCE5 did not have an effect on Luciferase activity. +, twofold increase; ++, fourfold increase; +++, sixfold increase; +/-, no change; - -, fourfold decrease; - - -, sixfold decrease; - - - -, approximately a tenfold decrease.
###end p 32
###begin p 33
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 145 156 145 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 357 368 357 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 455 461 455 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 762 773 762 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 864 870 864 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 1216 1222 1216 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 1304 1307 1304 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
To complement the analysis of individual MCEs, we performed an unbiased screen of the 5.5 kb region for any potential cis-regulatory elements by Luciferase assay. Fine mapping of the entire 1.5 kb upstream region and the first intron was performed using a series of deletion constructs (Figure S2 in Additional data file 2). Closer inspection by additional Luciferase deletion constructs refined the core promoter region to a 64 bp region upstream of the Rab3A 5' UTR (Figure S3 in Additional data file 2). Although two enhancer elements (Es) were mapped to E1 (-1,435, -1261) and E2 (-345, -123) regions, existence of repressor(s) (in the region between -802 and -346) cannot be excluded (Figure S4 in Additional data file 2). In addition, elements that reduce Luciferase activity (Ns) were found in the first intron, N1 (+240, +425) and N2 (+410, +556), and the Rab3A 3' UTR (+3,362, +3,860) (Figures S5 and S6 in Additional data file 2). Strikingly, all experimentally identified regulatory elements correspond to MCEs. MCE1 (-1,394, -1,216) and MCE2 (-305, -137) closely correlated with the two enhancers, while MCE4 (+281, +500) covered the N1 region and overlapped with the N2 region. Thus, in the case of the Rab3A locus, MCEs in intergenic regions are good indicators of critical tissue-specific cis-regulatory elements.
###end p 33
###begin p 34
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 648 649 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Next we computationally searched for putative transcription factor binding sites (TFBSs) in the 2.8 kb genomic region (starting from1.5 kb upstream to the end of the first intron of Rab3A) using the PWM_SCAN tool [42] and the 546 positional weight matrices (PWMs) corresponding to vertebrate transcription factors in TRANSFAC version 8.4 [43]. Based on a P-value threshold of 0.0002, we predicted 77 and 23 binding sites in MCE1 and MCE2, respectively. These included well-known neuronal transcription factors NGF1-C, CREB, and EBF1/Olf-1 (Table S2 in Additional data file 1). In addition, MCE4 contained sites for transcription factors REST/NRSF (P-value = 0.0001), which might contribute to MCE4's repressor effect.
###end p 34
###begin p 35
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 220 226 220 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 505 511 505 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 1200 1201 1200 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1502 1508 1500 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 714 719 <span type="species:ncbi:10090">mouse</span>
###xml 838 843 <span type="species:ncbi:10090">mouse</span>
###xml 1418 1423 <span type="species:ncbi:10090">mouse</span>
A group of binding sites located within a regulatory region may represent a CRM [44]. Therefore, we examined other genes that harbor the same CRM in their upstream regions for a similar expression pattern to that of the Rab3A gene. We searched 5 kb upstream regions of approximately 17,000 mouse RefSeq genes (version mm8) for the presence of the same set of binding sites as in Rab3A MCEs within a 500 bp window (see Materials and methods). This analysis identified 42 putative gene targets based on the Rab3A MCE1 CRM (Table S3 in Additional data file 1) and 13 gene targets based on the MCE2 CRM (data not shown). Next, we tested whether these 42 genes were expressed at significantly high levels in any of the mouse tissues for which genome-wide expression data are available. Based on the genome-wide gene expression profiles for 54 mouse tissues and 7 developmental stages (available in SymAtlas), we tested for each tissue, using the non-parametric Wilcoxon rank sum test (see Materials and methods), whether these 42 putative targets of the MCE1 CRM had a greater expression compared to all other genes. Overall, we found that these 42 genes had higher expression levels in 18 tissues with a P-value </= 0.05, of which 10 tissues were neural tissues such as cerebral cortex, preoptic area and substantia nigra. However, the 13 genes containing MCE2's CRM failed to show significant up-regulation in any of the mouse tissues tested. Our data suggest that at least a subset of CRMs, that is, for Rab3A MCE1, might be associated with a specific expression pattern.
###end p 35
###begin title 36
Identification of common motifs mediating neuronal-specific expression of the nine presynaptic genes
###end title 36
###begin p 37
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3C</italic>
###xml 85 91 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scamp5</italic>
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snap25</italic>
###xml 101 107 101 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stxbp1</italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Syn1</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SV2a</italic>
###xml 121 129 121 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Camk2N1 </italic>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 671 672 671 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 695 696 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 833 839 831 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
Next we hypothesized that co-expression of the nine presynaptic genes (Rab3A, Rab3C, Scamp5, Snap25, Stxbp1, Syn1, SV2a, Camk2N1 and DNM1) may be mediated via common CRMs. We have previously identified and characterized MCEs of 107 presynaptic genes [37]. Assuming that MCEs could serve as a reliable guide in the search for putative neuronal-specific CRMs, we searched for DNA-binding motifs enriched in the upstream MCEs near the nine genes with strong neuronal expression (cluster 1, Figure 1a) relative to the upstream MCEs near genes with nonspecific expression pattern (cluster 3, Figure 1c). This analysis revealed 16 PWMs enriched in cluster 1 genes' MCEs with a P-value </= 0.05 (Table 3); we also ensured that these predictions had low false discovery rates (FDRs; < 2.8%). These 16 motifs are among the TFBSs predicted in Rab3A MCE1 and MCE2, including binding sites for the well-known neuronal transcription factors REST/NRSF, CREB and NGF1c. Therefore, we asked if the presence of these sequence motifs is a likely determinant of neuronal-specific gene expression.
###end p 37
###begin p 38
Enriched transcription factor binding sites identified in cluster 1 multi-species conserved elements
###end p 38
###begin p 39
###xml 156 157 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The enrichment of 16 transcription factor binding sites over-represented in MCEs from cluster 1 genes in comparison to those in cluster 2 or 3 genes with a P-value < 0.05. FDR, false discovery rate.
###end p 39
###begin p 40
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 710 711 710 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 761 762 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 987 988 987 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Using the set of 16 transcription factor motifs over-represented in the cluster 1 genes' MCEs, we searched for 'neuronal-regulatory potential' in 3,347 intergenic MCEs corresponding to the 107 presynaptic genes (Figure 5). Specifically, we introduced a scoring function that scores each MCE as a sum of the likelihood-ratio of enrichment for each of the 16 motifs if they are present in the MCE. We ranked 3,347 MCEs by their scores representing the MCE's potential for regulating neuronal-specific expression in the range 0, for non-specific, to approximately 1,000, for the most neuronal-specific element. As expected, MCEs in cluster 1 have a greater score relative to those in cluster 2 (Wilcoxon rank sum P-value = 0.0015) and cluster 3 (Wilcoxon rank sum P-value = 2.2e-05) (Figure S7 in Additional data file 2). The differences remain significant even after we group all MCEs corresponding to a specific gene and use their median score as the summary statistic for the gene (both P-values </= 0.006). We note that while the above analysis is not meant to be an independent validation of our MCE ranking procedure, it does suggest that specific combinations of transcription factor motifs are enriched in MCEs in the vicinity of cluster 1 genes.
###end p 40
###begin p 41
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 0 146 0 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">General strategy to identify the common <italic>cis</italic>-regulatory modules for neuronal-specific expression and to score 3,347 MCEs from 107 presynaptic genes</bold>
General strategy to identify the common cis-regulatory modules for neuronal-specific expression and to score 3,347 MCEs from 107 presynaptic genes. GNF, Genomics Institute of the Novartis Research Foundation.
###end p 41
###begin p 42
###xml 175 181 175 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 722 733 722 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 763 774 763 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 853 864 853 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 1078 1084 1078 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 1292 1303 1292 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 1385 1396 1385 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 1429 1430 1429 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1708 1709 1708 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 793 797 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 906 911 <span type="species:ncbi:10090">mouse</span>
###xml 938 943 <span type="species:ncbi:10090">mouse</span>
###xml 980 985 <span type="species:ncbi:9606">human</span>
###xml 1023 1028 <span type="species:ncbi:9606">human</span>
Using this scoring strategy, we selected candidates of neuronal-specific enhancers from a pool of 3,347 intergenic MCEs for experimental validation. Apart from already tested Rab3A elements (MCE1 and MCE2), we selected 14 high-scoring MCEs (ranging from 1,006 to 90.5) for 12 genes (Table 4; see Materials and methods). Of the fourteen MCEs, eleven belong to cluster 1, two belong to cluster 2, and three belong to cluster 3 genes. In addition, as a negative control, for ten selected genes a low scoring MCE (score = 0) was also randomly chosen, matched with the high score MCE with regard to length and distance to target gene. We assessed the regulatory role of 24 MCEs (14 high scoring and 10 low scoring MCEs) in the Luciferase promoter assays, in which the Luciferase vector contained a SV40 promoter fused with the coding sequence of the firefly Luciferase gene. Tested cell lines included Neuro2a (mouse neuroblastoma cell), MEF (mouse embryonic fibroblast cell), HEK293 (human embryonic kidney cell 293) and Hela (human adenocarcinoma cell). Overall, including the two Rab3A MCEs (MCE1 and MCE2), we observed robust enhancer activities driven by 75% (12 of 16) of the high-scoring MCEs and in 30% (3 of 10) of the low-scoring MCEs in Neuro2a cells; none of the tested MCEs increased Luciferase expression in MEF, HEK293 and Hela cells except CAMK2G.23, which slightly induced Luciferase expression in Hela cells (Figure 6). Therefore, a majority (12 MCEs; 75%) of predicted neuronal enhancers revealed a regulatory role in the neuronal cell type. More specifically, of the total 26 MCEs tested, 12 were true positives, 4 were false positives, 7 were true negatives and 3 were false negatives (Table 4). This yields a nominal sensitivity of 12/15 = 80% and a nominal specificity of 7/11 = 63%. Our results, although based on a small testing set, indicate that this scoring strategy based on expression similarity and motif-enrichment provides a powerful tool for the identification of enhancers in a particular tissue of interest, in our case, neuronal tissue/cell type.
###end p 42
###begin p 43
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Functional validation of 14 high scoring MCEs and 10 low scoring MCEs listed in Table 3</bold>
###xml 89 100 89 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 157 168 157 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 228 239 228 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 256 262 256 262 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-d) </bold>
###xml 280 291 280 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 592 603 592 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 641 649 641 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 714 725 714 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 768 770 768 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 788 789 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 210 214 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Functional validation of 14 high scoring MCEs and 10 low scoring MCEs listed in Table 3. Luciferase constructs were generated by inserting each MCE into the Luciferase promoter vector (pGL3p), which contains a SV40 promoter and Luciferase coding sequence. (a-d) The corresponding Luciferase activity was examined in one neuronal cell line, Neuro2a cells (a), and three non-neuronal cell lines, Hela cells (b), HEK293 cells (c) and MEF cells (d). Each construct was tested in triplicate in each set of experiments. Every experiment of all 24 constructs was repeated at least three times. Each Luciferase construct was co-transfected with the Renilla pRLCMV vector for normalization. MCEs that significantly induced Luciferase activity are highlighted with an asterisk (P < 0.05, Student's t-test). The error bars represent the standard deviation of the mean of triplicates used for each construct.
###end p 43
###begin p 44
High scoring and corresponding low scoring multi-species conserved elements
###end p 44
###begin p 45
###xml 198 205 198 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK2N1</italic>
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN1 </italic>
###xml 216 222 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 324 335 324 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 477 479 477 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The list of 16 high scoring multi-species conserved elements (MCEs) and 10 low scoring MCEs for experimental validation (see Materials and method for selection detail). *Genomic regions upstream of CAMK2N1, SYN1 and Rab3A genes do not contain low-scoring MCEs. One of the high-scoring MCEs (STX18.12) failed to be cloned. A Luciferase assay in the Neuro2a cell line identified neuronal enhancers in 12 high-scoring MCEs and 3 low-scoring MCEs marked in bold (Student's t-test, P < 0.05).
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
Deciphering the cis-regulatory code for tissue-specific and developmental-stage-specific gene expression remains a significant challenge [44-48]. In this study we have focused on identifying common CRMs mediating neuronal expression, using a combined computational and experimental approach. In order to achieve biological specificity, we have restricted our investigation to neuronal-specific genes of a specific function, namely, presynaptic neurotransmitter release. Using a combination of TFBSs in conserved elements in nine genes with an abundant and restricted expression in neuronal tissues, we developed a combined computational-experimental strategy for the evaluation of the 'neuronal regulatory potential' of MCEs.
###end p 47
###begin p 48
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
Several slightly different approaches to identify CRMs mediating tissue-specific gene expression have been previously proposed [44-48]. Our approach differs from these in a few important ways. For instance, some of the other approaches employed genome-wide selection of co-expressed genes solely based on microarray expression profiles. This may recruit many genes that may belong to diverse pathways, therefore reducing the signal-to-noise ratio in subsequent analysis [49]. In contrast, we restricted our analysis to 150 genes known to be involved in synaptic transmission in presynaptic neurons; we further divided them into distinct expression clusters based on neuronal-related and non-neuronal-related tissue types. Nine presynaptic genes were found to have a striking neuronal-specific pattern that is likely co-regulated by common CRMs, whereas 72 genes with widespread and/or low levels of expression served as an internal control.
###end p 48
###begin p 49
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
A major challenge in the identification of TFBSs is that the binding motifs are usually short and degenerate and thus result in high false positive rates [32]. However, it has been shown that functional binding sites tend to be clustered [45]. Thus, by first identifying enriched motifs in the MCEs near the nine neuronal-specific genes, and by focusing on clustered occurrences of these motifs, we could reduce the rate of false positives. Seventy-two presynaptic genes with non-specific expression served as negative controls, further enhancing the specificity of CRM identification.
###end p 49
###begin p 50
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 446 452 446 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
Another challenging issue with many previous computational studies is the arbitrary selection of the proximal promoter region to search for enriched motifs and determine CRMs [44]. As previously shown, selection of evolutionarily conserved sequences from larger intergenic or intronic (MCE) regions may represent an alternative approach [44]. Consistent with these previous findings, a detailed experimental delineation of regulatory elements of Rab3A revealed a remarkable correspondence between functional elements and evolutionary conservation. However, it has been shown that, in many cases, functional elements are known to reside in non-conserved regions [50,51].
###end p 50
###begin p 51
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 904 915 904 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
To capture the contributions of various enriched motifs comprising a CRM, we chose a likelihood-ratio-based scoring metric specifically designed to assess the neuronal regulatory potential of a MCE. Our scoring metric weights the presence of a binding site based on its enrichment P-value, such that more enriched (lower P-value) motifs are weighted higher. This choice was based on the ability of the scoring metric to discriminate MCEs in the vicinity of genes expressed highly and specifically in neuronal cell types from MCEs near genes that are broadly expressed. In this respect, our approach is most similar to that taken in [44], where the authors estimated the weights based on an optimization procedure. Besides the statistical analysis used to verify the specificity of the MCE ranking procedure, we experimentally validated several high-scoring and low-scoring MCEs through a cell line-based Luciferase reporter assay. The comparison of neuronal cell line and non-neuronal cells offered, to some extent, a clue as to tissue/cell type specificity. Overall, based on 26 tested MCEs, we were able to predict neuronal-specific expression with roughly 75% sensitivity and 63% specificity. Although we have provided a proof-of-principle, we expect that a scoring metric trained on a larger set of validated neuronal-specific genes would permit a genome-wide prediction of neuronal enhancers.
###end p 51
###begin p 52
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 734 743 734 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 836 841 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 852 860 852 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 889 894 <span type="species:ncbi:10090">mouse</span>
From a methodological perspective, the strengths of our study include: carefully selected co-expressed genes with a related function (pathway); a two-pronged approach to determine cis-regulatory elements of one prominent gene - Rab3A; reliance on MCEs regardless of their proximity to the gene; pre-determination of enriched motifs to define the CRM; a weighted scoring strategy to rank MCEs according to their neuronal regulatory potential; and experimental validation of a subset of both high-scoring and low-scoring MCEs for their neuronal-specific enhancer properties. Certainly, despite these advantages, we are also aware of several limitations. First, our experimental validation is based on cell-culture experiments. However, in vitro methods cannot fully recapitulate endogenous expression patterns. As described in Pennacchio et al. [27], an in vivo enhancer assay in transgenic mouse embryos would be a more reliable and conclusive method to evaluate our findings. Moreover, although our scoring system is applicable to a genome-wide prediction of neuronal-specific enhancers, we still need to assess this application on a large set of gene and genomic elements.
###end p 52
###begin p 53
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1068 1079 1068 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 1266 1267 1266 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
This study focuses on identification of cis-regulatory elements responsible for neuronal expression; however, cis elements only partly determine gene expression, which is regulated by additional epigenetic factors such as nucleosome positioning, DNA methylation and a number of histone modifications [52-54]. Such epigenetic marks play critical roles in gene regulation in higher organisms. For instance, several studies have revealed the critical role of nucleosomes in chromatin structure and remodeling and, ultimately, in gene regulation. Nucleosome occupancy can block access to regulatory elements, thereby inhibiting the binding of transcription factors to specific DNA sequences. To assess the role of nucleosome occupancy, using a previously published computational modeling approach and the software program provided by the authors [55], we predicted the nucleosome occupancy probability for the 16 MCEs (including 50 bp flanking sequences). In our study, four MCEs with high scores for enrichment of neuronal-specific motifs did not show any enhancement of Luciferase gene expression. We found that relative to the 12 positive elements, the 4 negative elements had significantly greater probability of being occupied by nucleosomes (Mann-Whitney rank sum P-value = 0.04). This finding suggests that nucleosome occupancy, in addition to other levels of regulation, needs to be included in the evaluation of regulatory potential of genomic elements.
###end p 53
###begin p 54
###xml 209 212 209 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 353 356 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 796 799 796 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 317 322 <span type="species:ncbi:9606">human</span>
###xml 470 475 <span type="species:ncbi:9606">human</span>
###xml 1035 1040 <span type="species:ncbi:9606">human</span>
Conserved non-coding sequences are not only essential for gene expression, but are also associated with phenotypic variability and human disorders. To date, increasing attention has been focused on changes in cis-regulatory regions, such as substitutions or deletions, that might contribute to species uniqueness and human disorders [24,56,57]. Several cis-regulatory mutations are known to underlie diverse aspects of behavior, physiology and disease susceptibility in human [58-60]. For example, a non-coding single nucleotide polymorphism (RET+3) within a conserved enhancer element in the first intron of RET, a receptor tyrosin kinase, has been reported to be significantly associated with Hirschsprung disease featured by congenital aganglionosis with megacolon [61-63]. Our study decoding cis-regulatory elements required for neuronal gene expression could further facilitate investigation of genetic variations in functional regulatory elements, thus greatly improving our knowledge of how regulatory sequences are involved in human diseases.
###end p 54
###begin title 55
Conclusions
###end title 55
###begin p 56
###xml 110 118 110 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 122 131 122 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
We selected nine presynaptic genes that were most abundantly expressed in neural tissues and demonstrated, by in vivo and in vitro screens, that MCEs upstream of one of these genes, Rab3A, functioned as cis-regulatory elements. We then identified 16 transcription factor binding motifs that were enriched in intergenic MCEs in the vicinity of these nine genes. We devised a computational scoring metric based on the enriched motifs to assess an MCE's potential to function as a neuronal-specific enhancer. This scoring metric was shown to accurately detect neuronal-specific enhancers, based on experimental validation of a number of predicted MCEs using cell based assays. Thus, our study introduces a comprehensive strategy for identification of neuronal specific enhancers.
###end p 56
###begin title 57
Materials and methods
###end title 57
###begin title 58
Expression clustering of microarray profiles
###end title 58
###begin p 59
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
Mouse expression profiles are available from the Genomics Institute of the Novartis Research Foundation [38]; the data used were based on the analysis across 54 mouse tissues and 7 developmental stages on Affymetrix microarrays [64]. Normalized and filtered expression files were analyzed using TIGR Multiexperiment Viewer (MeV), a versatile microarray data analysis tool that incorporates algorithms for clustering, visualization, and statistical analysis [65,66]. We clustered 240 unique oligonucleotide probe sets that interrogated 126 different presynaptic genes into three distinct clusters. By closer inspection, we excluded 52 probes that hybridized to intergenic or intronic sequences. In addition, clustering of expression data placed 19 genes into more than one cluster and these genes were eliminated in the further analysis. As a result, 107 genes corresponding to 161 probes were clustered into 3 distinct expression groups by the hierarchical k-means clustering method.
###end p 59
###begin title 60
RT-PCR and quantitative PCR
###end title 60
###begin p 61
Brain tissues or cultured cells were homogenized in Trizol (Invitrogen, Carlsbad, CA, USA), and total RNA was extracted by the Trizol procedure and using an RNeasy mini prep kit (Qiagen, Valencia, CA, USA). For RT-PCR, 2 mug aliquots of DNase-treated RNA were reverse-transcribed using a High Capacity cDNA Archive kit (Applied Biosystems, Foster City, CA, USA) as described by the manufacturer.
###end p 61
###begin p 62
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 318 324 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 404 410 404 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
Reverse-transcribed products (2 to 4 ng) were used for PCR and the products obtained after 26 or 32 PCR cycles with the different primers were analyzed by agarose gel. Primer set F1/R1 was designed to be specific for the shorter transcript of Rab3A (ST), F2/R1 was designed to be specific for the longer transcript of Rab3A (LT), and F3/R1 was targeted to common sequences of both the ST and LT as total Rab3A mRNA. The beta-actin set was the control for RNA loading (Table S4 in Additional data file 1).
###end p 62
###begin p 63
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 784 790 784 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
cDNA products (2 to 4 ng) were used for quantitative PCR with a SYBR green PCR kit (Applied Biosystems). The primer set ST-F/R was used to detect the ST, the primer set LT-F/R to detect the LT, and the primer set E3-4-F/R to detect exons 3 and 4 of the total Rab3A mRNA. All samples were tested simultaneously with two primer sets: the control primer set (E3-4-F/R) and the test primer set (either ST-F/R or LT-F/R). This allowed ST/LT expression levels to be normalized to the total Rab3A level. All samples were tested in triplicate. Relative quantification (quantitative PCR) was performed on an ABI Prism 7900HT system and Ct values were analyzed by SDS2.2 software (Applied Biosystems). The relative mRNA quantity of ST and LT at each developmental stage was normalized to total Rab3A mRNA to obtain the relative ratio according to the calculation method in the user manual.
###end p 63
###begin title 64
Generation of EGFP reporter constructs
###end title 64
###begin p 65
###xml 143 160 143 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 192 197 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asc</italic>
###xml 366 369 366 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pac</italic>
###xml 756 759 756 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 765 768 765 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 143 159 <span type="species:ncbi:562">Escherichia coli</span>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
The EGFP reporter gene was introduced into BAC clone RPCI-23 433N2 (CHORI, BAC/PAC Resources, Oakland, CA, USA) by homologous recombination in Escherichia coli according to the method of Gong et al. [41]. Two 500 bp sequences (homology arms A and B) flanking mouse Rab3A exon 1 were amplified by PCR (Table S4 in Additional data file 1) and cloned into the AscI and PacI restriction sites flanking the EGFP coding sequence in the pLD53SCAEB shuttle vector. The modified vector was transformed into BAC host cell DH10B by electroporation. After two-step homologous recombination, the modified BACs were screened by PCR (Table S4 in Additional data file 1) to detect the two EGFP junctions and confirmed by Southern blot. Specifically, DNA was digested with EcoRI or HindIII, separated by electrophoresis on a 0.8% agarose gel and transferred to a nylon membrane. The blots were analyzed using the 'A box' or 'EGFP' as probe. Wild-type BAC DNA served as the negative control and shuttle vector as the positive control.
###end p 65
###begin p 66
###xml 107 110 107 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Swa</italic>
###xml 296 299 296 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 318 320 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 625 628 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 816 819 816 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 825 828 825 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 862 867 <span type="species:ncbi:10090">mouse</span>
The BAC-EGFP 15 kb construct was generated from the modified BAC clone. The modified BAC was digested with NotI and SwaI (Roche Applied Science, Indianapolis, IN, USA) and separated by electrophoresis on a 0.8% agarose gel. The 15 kb fragments were enriched by gel extraction and cloned into the NotI site of the pBSKS+ vector. Resultant colonies were screened by the presence of EGFP gene (Table S4 in Additional data file 1) and positive clones were confirmed by DNA sequencing. The BAC-EGFP 5.5 kb construct was directly amplified by PCR (Table S4 in Additional data file 1) upon the modified BAC and then cloned into the EcoRV site of the pBSKS+ vector. Resultant colonies were screened by the presence of EGFP and positive clones were confirmed by DNA sequencing. The two reporter constructs were linearized by NotI and SalI and used to generate transgenic mouse lines.
###end p 66
###begin title 67
###xml 29 44 <span type="species:ncbi:10090">transgenic mice</span>
Generation and genotyping of transgenic mice
###end title 67
###begin p 68
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
By pronuclear microinjection, reporter constructs were inserted into fertilized eggs derived from the intercross of the (BL6xSJL) F1 mouse strain (Transgenic Core Facility, University of Pennsylvania). Transgenic embryos were collected at 14.5 dpc. Tail snips of transgenic embryos were incubated overnight in 700 mul of lysis buffer (10 mM Tris, pH 8; 10 mM EDTA, pH 8; 0.1 M NaCl; 2% SDS) supplemented with 1 mug/mul proteinase K (Sigma-Aldrich, St. Louis, MO, USA). DNA was extracted using standard phenol-chloroform procedures, precipitated with ethanol, and dissolved in 10 mM Tris/10 mM EDTA. PCR was performed to determine the presence of the EGFP gene.
###end p 68
###begin title 69
Immunohistochemistry of transgenic positive embryos
###end title 69
###begin p 70
###xml 461 462 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 463 465 451 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 646 651 <span type="species:ncbi:9796">horse</span>
###xml 1031 1037 <span type="species:ncbi:9986">rabbit</span>
###xml 1102 1107 <span type="species:ncbi:9796">horse</span>
###xml 1108 1114 <span type="species:ncbi:3726">radish</span>
Transgenic embryos (three transgenic positives and three negatives) at 14.5 dpc were fixed in 4% paraformaldehyde overnight at 4degreesC, dehydrated using graded alcohols and embedded in paraffin. Five-micron sections were deposited onto superfrost-coated slides and air dried. After heating at 65degreesC for 20 minutes, slides were deparaffinized in three rounds of xylene. Endogenous peroxidase activity was blocked with incubation in 100% methanol with 1% H2O2 for 20 minutes at room temperature. Slides were rehydrated using graded alcohol at room temperature and placed into a humidifier. After slides were bathed with blocking buffer (10% horse serum, 0.1% tween-20, dilute with 1x phosphate-buffered saline) for 30 minutes at room temperature, each slide was then covered with the primary anti-GFP antibody (15 mug/ml; #11122, Invitrogen) and left overnight at 4degreesC. A Biotin-Streptavidin Amplified kit (Biogenex Laboratories Inc, San Ramon, CA, USA) was then used as follows. Incubation of biotinylate secondary anti-rabbit antibody was followed by application of streptavidin conjugated horse radish peroxidase labeled antibody. Each incubation lasted 30 minutes at room temperature and phosphate-buffered saline was used as wash. The DAB chromogen was applied for 5 minutes (color reaction product: brown). The slides were then counterstained with hematoxylin, dehydrated and covered by a coverslip. All images were visualized using conventional microscopy.
###end p 70
###begin title 71
###xml 14 25 14 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
Generation of Luciferase constructs
###end title 71
###begin p 72
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 14 25 14 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 130 149 130 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Firefly Luciferase </italic>
###xml 423 434 423 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 491 494 491 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 508 527 508 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Firefly Luciferase </italic>
###xml 652 663 652 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
Rab3A-related Luciferase constructs were generated by inserting the genomic sequence of the Rab3A locus into the SmaI site of the Firefly Luciferase pGL3-basic vector (pGL series), pGL3-promoter vector (pGLp series) or pGL3-control vector (pGLc series) (Promega Corporation, Madison, WI, USA). PCR was used to generate insertion fragments using related primer sets listed in Table S4 in Additional data file 1. MCE-related Luciferase constructs were generated by inserting each MCE into the SmaI site of the Firefly Luciferase pGL3-promoter vector. MCEs were amplified by PCR using related primer sets listed in Table S4 in Additional data file 1. All Luciferase constructs were confirmed by sequencing.
###end p 72
###begin title 73
###xml 27 38 27 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
Transient transfection and Luciferase assays
###end title 73
###begin p 74
###xml 287 306 287 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Firefly Luciferase </italic>
###xml 321 340 321 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla Luciferase </italic>
###xml 574 593 573 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Firefly Luciferase </italic>
###xml 623 642 621 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla Luciferase </italic>
###xml 1379 1398 1374 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Firefly Luciferase </italic>
###xml 1402 1421 1397 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla Luciferase </italic>
###xml 1446 1457 1441 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
###xml 1615 1616 1610 1611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1672 1673 1667 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 133 139 <span type="species:ncbi:9913">bovine</span>
###xml 519 525 <span type="species:ncbi:9913">bovine</span>
###xml 836 842 <span type="species:ncbi:9913">bovine</span>
Cells were plated in 6-well plates and grown to 60% confluence in growth medium (Dulbecco's modified Eagle's medium (DMEM), 5% fetal bovine serum, 1% L-glutamin, 1% MEM Non-essential Amino Acid solution, 1% antibiotics; Sigma-Aldrich, St. Louis, MO, USA). Cells were co-transfected with Firefly Luciferase constructs and Renilla Luciferase pRLCMV [pRLCMVrenilla] vector (Promega Corportaion) using the liposome-mediated Fugene 6 Reagent (Roche Applied Science,) at a DNA/lipid ratio of 2:1 in DMEM medium without fetal bovine serum. On the day of the transfection, 3 mug of Firefly Luciferase construct DNA and 0.06 mug of Renilla Luciferase vector were mixed with 6 mul of Transfast reagent and incubated at room temperature for 20 minutes. After incubation, plated cells were changed with fresh modified growth medium (DMEM, 1% fetal bovine serum, 1% L-glutamin, 1% MEM Non-essential Amino Acid solution, 1% antibiotics; Sigma-Aldrich) and overlaid with DNA/Transfast mixture. Cells were incubated for 48 hours and harvested with 500 mul of passive lysis buffer (Promega Corporation). Luciferase activities were measured with 20 mul of protein extract solution using the dual-luciferase reporter assay system (Promega Corporation) and a Bio-Rad luminometer (Bio-Rad, Hercules, CA, USA). Each construct was tested in triplicate in each set of experiments. The ratio between the Firefly Luciferase and Renilla Luciferase was used as the relative Luciferase activity for each construct. Every experiment for all 24 constructs was repeated at least three times. For experimental validation of MCEs, we used Student's t-test to calculate statistical significance, in which a P-value < 0.05 was considered to be significant.
###end p 74
###begin title 75
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
Identification of target genes sharing the CRMs of the Rab3A MCEs and their tissue-specific expression
###end title 75
###begin p 76
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 682 687 <span type="species:ncbi:10090">mouse</span>
Based on putative TFBSs in Rab3A MCE1, we first merged all overlapping binding sites whose corresponding PWMs were 'similar'. For PWM-pair similarity we used a previously published metric based on relative entropy and applied a cutoff P-value of 0.02 [67]. Among all merged hits we retained the best scoring binding site. This yielded seven PWMs for MCE1. We then expanded each of the seven PWMs to include other related PWMs, using the same operational definition of similarity as above; we thus had seven families of PWMs. Based on genome-wide annotation of putative binding sites using our previously described phylogenetic footprinting approach [42], we searched for additional mouse transcripts that harbored at least one member of each of the seven PWM families within a 500 bp window in their 5 kb upstream region. We thus identified 42 transcripts. Using the same strategy, MCE2 also yielded 7 families of related PWMs and 13 gene targets were identified by this CRM in the genome-wide search.
###end p 76
###begin p 77
We downloaded the genome-wide expression profiles for 61 tissues from Novartis. We specifically obtained the GCRMA (Guanine Cytosine Robust Multi-Array Analysis) processed expression values. For each tissue, using the Wilcoxon rank sum test, we tested the null hypothesis that the expression levels of these gene targets were no greater than those of the other genes in that tissue.
###end p 77
###begin title 78
Identification of over-represented motifs in cluster 1 genes
###end title 78
###begin p 79
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 195 200 <span type="species:ncbi:10090">mouse</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 262 272 <span type="species:ncbi:9598">chimpanzee</span>
###xml 274 277 <span type="species:ncbi:9615">dog</span>
###xml 279 282 <span type="species:ncbi:10116">rat</span>
###xml 284 291 <span type="species:ncbi:9031">chicken</span>
###xml 293 303 <span type="species:ncbi:7955">zebra fish</span>
The MCEs of presynaptic genes were defined by Hadley et al. [37]. Using the computational tool phastCons [68], MCEs were defined as the most conserved elements from genome-wide alignments of the mouse genome with seven other vertebrate genomes, including human, chimpanzee, dog, rat, chicken, zebra fish and puffer fish.
###end p 79
###begin p 80
Using our PWM_SCAN tool and TRANSFAC PWMs as described above, we identified the putative binding sites in all MCEs upstream of the 107 presynaptic genes until the next neighboring gene. For each motif, we compared the number of occurrences in the MCEs corresponding to cluster 1 genes relative to the MCEs corresponding to cluster 3 genes and estimated the significance of enrichment using 1,000 random permutations.
###end p 80
###begin p 81
###xml 35 36 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 405 414 405 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a priori </italic>
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 593 594 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
We then estimated the FDR for each P-value threshold based on permutations. From the entire set of MCEs that was used as a background control for the above enrichment analysis, we randomly selected 158 MCEs (same number as the cluster 1 5' MCEs used for enrichment analysis) and estimated the enrichment of 546 PWMs. Based on 100 randomizations, we have, in effect, done 54,600 tests of enrichment. Since a priori we do not expect any meaningful enrichment in these randomly selected MCEs, the fraction of tests that qualify a certain P-value threshold provide an estimate of the FDR for that P-value.
###end p 81
###begin title 82
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cis</italic>
Cis-regulatory module scoring metric
###end title 82
###begin p 83
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 511 512 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 513 514 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 540 541 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 589 591 589 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m1</italic>
###xml 593 595 593 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m2</italic>
###xml 602 604 602 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mk</italic>
Given the 16 motifs enriched in cluster 1 MCEs, we hypothesized that the co-occurrence of some of these motifs in an MCE may be indicative of the MCE's role as a neuronal-specific enhancer. However, we wished to weight motifs proportional to their enrichment score. For a motif with a Fisher exact test P-value of p, we set its weight as (1 - p)/p, which can be interpreted as the likelihood ratio of the probability of the motif not occurring by chance to the probability of the motif occurring by chance. Let p(x) be the P-value of motif x. Thus, for an MCE having occurrences of motifs m1, m2, ..., mk, the score is given by:
###end p 83
###begin p 84

###end p 84
###begin title 85
###xml 25 36 25 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
Selection of 16 MCEs for Luciferase assay
###end title 85
###begin p 86
###xml 554 560 554 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3C </italic>
###xml 919 926 919 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAMK2N1</italic>
###xml 928 933 928 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN1 </italic>
###xml 937 942 937 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 1086 1097 1086 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luciferase </italic>
Approximately 3,347 upstream MCEs from 107 presynaptic genes were ranked by scores. We selected the top 30 MCEs, corresponding to 12 presynaptic genes. Among the 12 genes, 6 belong to cluster 1, 2 belong to cluster 2 and 4 belonged to cluster 3. For each gene, normally one MCE with the highest score was chose for evaluation. Two MCEs (one with the highest score and one with a lower score) were chosen only if the gene was a cluster 1 gene and had several MCEs in the top 30. To complete the cluster 1 gene list, a low score MCE (score = 96.13) of the Rab3C gene was also chosen. All selected MCEs were carefully inspected with regard to their conservation, relative position to neighboring genes and length. In addition, as a negative control, for each selected gene a zero scoring MCE was randomly chosen, matched to the high score MCEs with regard to their length and distance to the target gene. (Exceptions were CAMK2N1, SYN1 and Rab3A, which did not have a zero scoring MCE, and one of the 17 high scoring MCEs (STX18.12) failed to be cloned.) Experimental validation using the Luciferase assay was as described above.
###end p 86
###begin title 87
Abbreviations
###end title 87
###begin p 88
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
BAC: bacterial artificial chromosome; CRM: cis-regulatory module; dpc: days post coitum; DMEM: Dulbecco's modified Eagle's medium; E: enhancer element of Rab3A gene; EGFP: enhanced green fluorescent protein; FDR: false discovery rate; GCRMA: Guanine Cytosine Robust Multi-Array Analysis; LT: longer transcript of Rab3A; MCE: multi-species conserved element; N: element with a negative function in Rab3A gene expression; PWM: positional weight matrix; ST: shorter transcript of Rab3A; TFBS: transcription factor binding site; UTR: untranslated region.
###end p 88
###begin title 89
Authors' contributions
###end title 89
###begin p 90
RL carried out the clustering analysis of presynaptic genes, performed experiments and drafted the manuscript. SH conducted CRM analysis and designed the scoring strategy. MB conceived of the study, and participated in its design and coordination. All authors contributed to the writing of the paper, and read and approved the final manuscript.
###end p 90
###begin title 91
Additional data files
###end title 91
###begin p 92
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
The following additional data are available with the online version of this paper: Tables S1 to S4 (Additional data file 1); Figures S1 to S7 (Additional data file 2).
###end p 92
###begin title 93
Supplementary Material
###end title 93
###begin title 94
Additional data file 1
###end title 94
###begin p 95
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
Table S1 lists 107 presynaptic genes in corresponding expression clusters. Table S2 lists TFBSs identified in Rab3A MCEs. Table S3 lists 42 additional genes potentially regulated by Rab3A ECR1's CRM and their expression levels. Table S4 lists all primer sets used in this study.
###end p 95
###begin p 96
Click here for file
###end p 96
###begin title 97
Additional data file 2
###end title 97
###begin p 98
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A</italic>
###xml 293 299 293 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
###xml 407 413 407 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab3A </italic>
Figure S1 shows Rab3A amplification in cDNA and genomic DNA (gDNA) samples. Figure S2 shows the screen of functional elements in the non-coding region of the Rab3A locus. Figure S3 shows fine mapping of the promoter region of Rab3A. Figure S4 shows the screen of the 1.5 kb upstream region of Rab3A for potential regulatory element(s). Figure S5 shows the screen and characterization of the first intron of Rab3A for regulatory element(s). Figure S6 shows the masking of MCE5 by the presence of MCE1 and MCE2 in Neuro2a cells. Figure S7 shows the statistical evaluation of the scoring strategy for MCEs.
###end p 98
###begin p 99
Click here for file
###end p 99
###begin title 100
Acknowledgements
###end title 100
###begin p 101
We thank Douglas Epstein and Yongsu Jeong for their advice in the initial phase of the project, for providing plasmids and for commenting on the manuscript, and Dexter Hadley for help with expression and comparative sequence analysis. This work was supported by NIH grant R01 MH604687 and the NARSAD distinguished Investigator Award to MB, and by NIH grant R01GM085226 to SH.
###end p 101
###begin article-title 102
The synaptic vesicle cycle.
###end article-title 102
###begin article-title 103
Neurotransmitter release.
###end article-title 103
###begin article-title 104
RIM1alpha forms a protein scaffold for regulating neurotransmitter release at the active zone.
###end article-title 104
###begin article-title 105
Synapsin is a novel Rab3 effector protein on small synaptic vesicles. I. Identification and characterization of the synapsin I-Rab3 interactions in vitro and in intact nerve terminals.
###end article-title 105
###begin article-title 106
Synapsin is a novel Rab3 effector protein on small synaptic vesicles. II. Functional effects of the Rab3A-synapsin I interaction.
###end article-title 106
###begin article-title 107
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Genome-wide gene expression profiles of the developing mouse hippocampus.
###end article-title 107
###begin article-title 108
Hippocampal synaptogenesis in cell culture: developmental time course of synapse formation, calcium influx, and synaptic protein distribution.
###end article-title 108
###begin article-title 109
Cellular and molecular mechanisms of presynaptic assembly.
###end article-title 109
###begin article-title 110
Mechanisms of vertebrate synaptogenesis.
###end article-title 110
###begin article-title 111
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Developmental and regional expression of three new members of the ras-gene family in the mouse brain.
###end article-title 111
###begin article-title 112
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Localization of the ras-like rab3A protein in the adult rat brain.
###end article-title 112
###begin article-title 113
Accumulation of mRNAs encoding synaptic vesicle-specific proteins precedes neurite extension during early neuronal development.
###end article-title 113
###begin article-title 114
Differential synaptic vesicle protein expression in the barrel field of developing cortex.
###end article-title 114
###begin article-title 115
Expression of Rab3A GTPase and other synaptic proteins is induced in differentiated NT2N neurons.
###end article-title 115
###begin article-title 116
###xml 83 86 <span type="species:ncbi:10116">rat</span>
Developmental changes in the localization of the synaptic vesicle protein rab3A in rat brain.
###end article-title 116
###begin article-title 117
###xml 94 97 <span type="species:ncbi:10116">rat</span>
Localization and subcellular distribution of smg p25A, a ras p21-like GTP-binding protein, in rat brain.
###end article-title 117
###begin article-title 118
Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains.
###end article-title 118
###begin article-title 119
###xml 128 136 <span type="species:ncbi:9606">patients</span>
Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients.
###end article-title 119
###begin article-title 120
Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease.
###end article-title 120
###begin article-title 121
Genomic strategies to identify mammalian regulatory sequences.
###end article-title 121
###begin article-title 122
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Insights from human/mouse genome comparisons.
###end article-title 122
###begin article-title 123
###xml 69 74 <span type="species:ncbi:9606">human</span>
Comparative genomic tools and databases: providing insights into the human genome.
###end article-title 123
###begin article-title 124
Comparative genomics at the vertebrate extremes.
###end article-title 124
###begin article-title 125
Conserved non-genic sequences - an unexpected feature of mammalian genomes.
###end article-title 125
###begin article-title 126
###xml 54 59 <span type="species:ncbi:9606">human</span>
Close sequence comparisons are sufficient to identify human cis-regulatory elements.
###end article-title 126
###begin article-title 127
Enhancer identification through comparative genomics.
###end article-title 127
###begin article-title 128
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
In vivo enhancer analysis of human conserved non-coding sequences.
###end article-title 128
###begin article-title 129
VISTA Enhancer Browser
###end article-title 129
###begin article-title 130
Bioinformatics in the post-sequence era.
###end article-title 130
###begin article-title 131
Transcriptional regulation of protein complexes and biological pathways.
###end article-title 131
###begin article-title 132
###xml 46 51 <span type="species:ncbi:9606">human</span>
CREME: Cis-Regulatory Module Explorer for the human genome.
###end article-title 132
###begin article-title 133
Prediction of cis-regulatory elements using binding site matrices - the successes, the failures and the reasons for both.
###end article-title 133
###begin article-title 134
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">De novo </italic>
De novo cis-regulatory module elicitation for eukaryotic genomes.
###end article-title 134
###begin article-title 135
A global genomic transcriptional code associated with CNS-expressed genes.
###end article-title 135
###begin article-title 136
Functional architecture and evolution of transcriptional elements that drive gene coexpression.
###end article-title 136
###begin article-title 137
Identification of tissue-specific cis-regulatory modules based on interactions between transcription factors.
###end article-title 137
###begin article-title 138
Patterns of sequence conservation in presynaptic neural genes.
###end article-title 138
###begin article-title 139
SymAtlas
###end article-title 139
###begin article-title 140
The transcriptional landscape of the mammalian genome.
###end article-title 140
###begin article-title 141
UCSC Genome Bioinformatics
###end article-title 141
###begin article-title 142
Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication.
###end article-title 142
###begin article-title 143
###xml 60 65 <span type="species:ncbi:9606">human</span>
Identification of transcription factor binding sites in the human genome sequence.
###end article-title 143
###begin article-title 144
TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes.
###end article-title 144
###begin article-title 145
Identification of regulatory regions which confer muscle-specific gene expression.
###end article-title 145
###begin article-title 146
###xml 128 138 <span type="species:ncbi:7227">Drosophila</span>
Exploiting transcription factor binding site clustering to identify cis-regulatory modules involved in pattern formation in the Drosophila genome.
###end article-title 146
###begin article-title 147
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
DNA motifs in human and mouse proximal promoters predict tissue-specific expression.
###end article-title 147
###begin article-title 148
###xml 44 49 <span type="species:ncbi:9606">human</span>
Predicting tissue-specific enhancers in the human genome.
###end article-title 148
###begin article-title 149
Computational prediction of novel components of lung transcriptional networks.
###end article-title 149
###begin article-title 150
Computational biology: toward deciphering gene regulatory information in mammalian genomes.
###end article-title 150
###begin article-title 151
Distinguishing regulatory DNA from neutral sites.
###end article-title 151
###begin article-title 152
Evolution of transcription factor binding sites in Mammalian gene regulatory regions: conservation and turnover.
###end article-title 152
###begin article-title 153
Nucleosome positioning and gene regulation.
###end article-title 153
###begin article-title 154
Transcription regulation and animal diversity.
###end article-title 154
###begin article-title 155
Regulation of gene expression in the nervous system.
###end article-title 155
###begin article-title 156
A genomic code for nucleosome positioning.
###end article-title 156
###begin article-title 157
The evolutionary significance of cis-regulatory mutations.
###end article-title 157
###begin article-title 158
###xml 45 50 <span type="species:ncbi:9606">human</span>
Genome-wide analysis of natural selection on human cis-elements.
###end article-title 158
###begin article-title 159
Regulatory polymorphisms underlying complex disease traits.
###end article-title 159
###begin article-title 160
###xml 54 60 <span type="species:ncbi:9606">humans</span>
Abundant raw material for cis-regulatory evolution in humans.
###end article-title 160
###begin article-title 161
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human-specific gain of function in a developmental enhancer.
###end article-title 161
###begin article-title 162
A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk.
###end article-title 162
###begin article-title 163
Evaluation of the RET regulatory landscape reveals the biological relevance of a HSCR-implicated enhancer.
###end article-title 163
###begin article-title 164
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 54 63 <span type="species:ncbi:7955">zebrafish</span>
Conservation of RET regulatory function from human to zebrafish without sequence similarity.
###end article-title 164
###begin article-title 165
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
A gene atlas of the mouse and human protein-encoding transcriptomes.
###end article-title 165
###begin article-title 166
Cluster analysis and display of genome-wide expression patterns.
###end article-title 166
###begin article-title 167
Microarray Software Suite
###end article-title 167
###begin article-title 168
###xml 67 72 <span type="species:ncbi:9606">human</span>
Transcriptional genomics associates FOX transcription factors with human heart failure.
###end article-title 168
###begin article-title 169
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes.
###end article-title 169

